Preimplantation Genetic Testing Market is Driven Swiftly By Declining Fertility Rates Worldwide Till 2022

CITY – Northbrook, Country – USA, 2020-Jan-09 — /EPR Network/ —

The global preimplantation genetic testing market size is projected to reach USD 541.8 Million by 2022 from USD 336.4 Million in 2017, at a CAGR of 10.0%. Factors driving the growth of this market include the growing rate of infertility across the world and increasing public-private investments in the field of preimplantation genetic testing among others.

Browse 85 Market Data Tables and 42 Figures spread through 204 Pages and in-depth TOC on “Preimplantation Genetic Testing Market Size, Share, Trends Analysis Report by Type (Genetic Diagnosis/Genetic Screening), Technology (NGS, PCR, FISH, CGH, SNP), Products & Services, Application , End User (Fertility Clinics, Research) – Forecast to 2022”

Download PDF Boucher:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=605

The rising infertility rate across the world is the key factor driving the growth of the market. Geographically, this market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

The global preimplantation genetic testing market is segmented by technology, product & service, procedure type, applications, end user and region. Based on technology, the market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at a faster rate owing to the increasing applications of preimplantation genetic testing for different cancer cases.

All The Insights & Data Facts: https://www.marketsandmarkets.com/Market-Reports/preimplantation-genetic-testing-market-605.html

The global preimplantation genetic testing market, by product & service, is segmented into instruments, reagents & consumables, and software & services. The reagents & consumables segment accounted for the largest share of the global preimplantation testing market in 2016. Analysis of the market developments between 2014 and 2017 (January) show that agreements, partnerships, and collaborations were the most widely adopted growth strategies by players in the market.

Illumina, Inc. (U.S.), CooperSurgical, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Rubicon Genomics, Inc. (U.S.), Oxford Gene Technology (U.K.), Yikon Genomics (China), and SciGene Corporation (U.S.) are some of the major manufacturers in this market; whereas, Beijing Genomics Institute (BGI) (China), Good Start Genetics (U.S.), CombiMatrix Corporation (U.S.), Genea Limited (Australia), Invicta Genetics (Poland), and Progenesis (U.S.) are some of the major service providers.

Preimplantation Genetic Testing Market Scope of the Report:

This research report categorizes the preimplantation genetic testing market into the following segments and sub-segments:

Preimplantation Genetic Testing Market: By Technology

• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescent In-Situ Hybridization (FISH)
• Comparative Genomic Hybridization (CGH)
• Single Nucleotide Polymorphism (SNP)

Preimplantation Genetic Testing Market: By Product & Service

• Reagents & Consumables
• Instruments
• Software & Services

Preimplantation Genetic Testing Market: By Procedure Type

• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis

Preimplantation Genetic Testing Market: By Application

• Aneuploidy
• Structural Chromosomal Abnormalities
• Translocations
• Deletions
• Duplications
• Inversions
• Single Gene Disorders
• X-linked Disorders
• HLA Typing
• Gender Identification

Preimplantation Genetic Testing Market: By End User

• Maternity Centers & Fertility Clinics
• Hospitals, Diagnostic Labs, and Service Providers
• Research Laboratories & Academic Institutes

Preimplantation Genetic Testing Market: By Region

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
• Rest of Asia-Pacific
• Rest of the World

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com